Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-05
2009-02-03
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S064000
Reexamination Certificate
active
07485649
ABSTRACT:
The instant invention provides for compounds which comprise fused pyrazoles that inhibit CHK1 activity. The invention also provides for compositions comprising such inhibitory compounds and methods of inhibiting CHK1 activity by administering the compound to a patient in need of treatment of cancer.
REFERENCES:
patent: 5153196 (1992-10-01), McQuaid et al.
patent: 2007/0254879 (2007-11-01), Arrington et al.
patent: WO03/035618 (2003-05-01), None
patent: WO2005/028474 (2005-03-01), None
patent: WO2006/074281 (2006-07-01), None
patent: WO 2007/081572 (2007-07-01), None
Brnardic Edward J.
Fraley Mark E.
Garbaccio Robert M.
Aulakh Charanjit S
Merck & Co. , Inc.
Muthard David A.
Su Li
LandOfFree
Inhibitors of checkpoint kinases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of checkpoint kinases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of checkpoint kinases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073464